Lipopolysaccharide Receptors
"Lipopolysaccharide Receptors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Glycolipid-anchored membrane glycoproteins expressed on cells of the myelomonocyte lineage including MONOCYTES; MACROPHAGES; and some GRANULOCYTES. They function as receptors for the complex of lipopolysaccharide (LPS) and LPS-binding protein.
| Descriptor ID |
D018950
|
| MeSH Number(s) |
D12.776.395.550.448.100 D12.776.543.484.500.100 D12.776.543.550.418.100 D12.776.543.750.705.045 D23.050.301.264.900.045 D23.101.100.900.045
|
| Concept/Terms |
Lipopolysaccharide Receptors- Lipopolysaccharide Receptors
- Lipoglycan Receptor
- Receptor, Lipoglycan
- Receptors, Lipopolysaccharide
- CD14 Antigens
- Antigens, CD14
- LPS Receptor
- Receptor, LPS
- CD14 Monocyte Differentiation Antigen
- CD14 Antigen
|
Below are MeSH descriptors whose meaning is more general than "Lipopolysaccharide Receptors".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Glycoproteins [D12.776.395]
- Membrane Glycoproteins [D12.776.395.550]
- GPI-Linked Proteins [D12.776.395.550.448]
- Lipopolysaccharide Receptors [D12.776.395.550.448.100]
- Membrane Proteins [D12.776.543]
- Lipid-Linked Proteins [D12.776.543.484]
- GPI-Linked Proteins [D12.776.543.484.500]
- Lipopolysaccharide Receptors [D12.776.543.484.500.100]
- Membrane Glycoproteins [D12.776.543.550]
- GPI-Linked Proteins [D12.776.543.550.418]
- Lipopolysaccharide Receptors [D12.776.543.550.418.100]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, Immunologic [D12.776.543.750.705]
- Lipopolysaccharide Receptors [D12.776.543.750.705.045]
- Biological Factors [D23]
- Antigens [D23.050]
- Antigens, Surface [D23.050.301]
- Antigens, Differentiation [D23.050.301.264]
- Antigens, Differentiation, Myelomonocytic [D23.050.301.264.900]
- Lipopolysaccharide Receptors [D23.050.301.264.900.045]
- Biomarkers [D23.101]
- Antigens, Differentiation [D23.101.100]
- Antigens, Differentiation, Myelomonocytic [D23.101.100.900]
- Lipopolysaccharide Receptors [D23.101.100.900.045]
Below are MeSH descriptors whose meaning is more specific than "Lipopolysaccharide Receptors".
This graph shows the total number of publications written about "Lipopolysaccharide Receptors" by people in this website by year, and whether "Lipopolysaccharide Receptors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 1 | 2 |
| 2008 | 1 | 0 | 1 |
| 2009 | 0 | 3 | 3 |
| 2014 | 2 | 1 | 3 |
| 2015 | 0 | 2 | 2 |
| 2016 | 2 | 2 | 4 |
| 2017 | 11 | 13 | 24 |
| 2018 | 8 | 11 | 19 |
| 2019 | 1 | 6 | 7 |
| 2020 | 3 | 3 | 6 |
| 2021 | 4 | 2 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Lipopolysaccharide Receptors" by people in Profiles.
-
Presepsin value predicts the risk of developing severe/critical COVID-19 illness: results of a pooled analysis. Clin Chem Lab Med. 2022 01 26; 60(1):e1-e3.
-
CD169 Defines Activated CD14+ Monocytes With Enhanced CD8+ T Cell Activation Capacity. Front Immunol. 2021; 12:697840.
-
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes. JCI Insight. 2021 06 18; 6(13).
-
Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients. Front Immunol. 2021; 12:625732.
-
Circulating furin, IL-6, and presepsin levels and disease severity in SARS-CoV-2-infected patients. Sci Prog. 2021 06; 104(2_suppl):368504211026119.
-
Letter to the Editor: CD14+HLA-DR+ Cells in Patients May Be a Biomarker Reflecting the Progression of COVID-19. Viral Immunol. 2021 10; 34(8):579-581.
-
Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV-2 infection. Cell Rep Med. 2021 06 15; 2(6):100291.
-
Single-Cell RNA Sequencing Analysis of the Immunometabolic Rewiring and Immunopathogenesis of Coronavirus Disease 2019. Front Immunol. 2021; 12:651656.
-
Levels of Soluble CD14 and Tumor Necrosis Factor Receptors 1 and 2 May Be Predictive of Death in Severe Coronavirus Disease 2019. J Infect Dis. 2021 03 03; 223(5):805-810.
-
Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia. Front Immunol. 2021; 12:627548.